Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: Findings from a large electronic health records database

Journal of Psychiatric Research

Volumn 45, Issue 11, 2011, Pages 1453-1462

  Wu, Li Tzy ^a   Gersing, Ken ^a   Burchett, Bruce ^a   Woody, George E ^b   Blazer, Dan G ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TREATMENT RESEARCH INSTITUTE   (United States)

Author keywords

Attention deficit hyperactivity disorder; Comorbidity; Comparative effectiveness research; Electronic health records; Mood disorder; Personality disorder; Relational disorder; Substance use disorder

Indexed keywords

ALCOHOL; CANNABIS; DIAMORPHINE; NICOTINE; OPIATE; SEDATIVE AGENT;

ADJUSTMENT DISORDER; ADOLESCENT; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CANNABIS ADDICTION; CHILD; CONDUCT DISORDER; DISEASE ASSOCIATION; EATING DISORDER; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; IMPULSE CONTROL DISORDER; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; MENTAL PATIENT; MOOD DISORDER; PERSONALITY DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOSIS; SCHOOL CHILD; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

EID: 80053976161     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.06.012     Document Type: Article

References (59)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Publishing, Washington, DC. 4th ed., text revision.
2. Armstrong T.D., Costello E.J. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity. Journal of Consulting and Clinical Psychology 2002, 70:1224-1239.
3. Baker A.L., Hides L., Lubman D.I. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review. Journal of Clinical Psychiatry 2010, 71:247-254.
4. Beyer J., Kuchibhatla M., Gersing K., Krishnan K.R. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005, 30:401-404.
5. Beyer J.L., Taylor L., Gersing K.R., Krishnan K.R. Prevalence of HIV infection in a general psychiatric outpatient population. Psychosomatics 2007, 48:31-37.
6. Brook J.S., Richter L., Rubenston E. Consequences of adolescent drug use on psychiatric disorders in early adulthood. Annals of Medicine 2000, 32:401-407.
7. Bubier J.L., Drabick D.A. Co-occurring anxiety and disruptive behavior disorders: the roles of anxious symptoms, reactive aggression, and shared risk processes. Clinical Psychology Review 2009, 29:658-669.
8. Clark D.B., Martin C.S., Cornelius J.R. Adolescent-onset substance use disorders predict young adult mortality. Journal of Adolescent Health 2008, 42:637-639.
9. Cohen P. Child development and personality disorder. Psychiatric Clinics of North America 2008, 31:477-493.
10. Compton S.N., Burns B.J., Helen L.E., Robertson E. Review of the evidence base for treatment of childhood psychopathology: internalizing disorders. Journal of Consulting and Clinical Psychology 2002, 70:1240-1266.
11. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004, 291:2114-2121.
12. Costello E.J. Psychiatric predictors of adolescent and young adult drug use and abuse. Drug and Alcohol Dependence 2007, 88(Suppl. 1):S1-S3.
13. Dakof G.A. Understanding gender differences in adolescent drug abuse: issues of comorbidity and family functioning. Journal of Psychoactive Drugs 2000, 32:25-32.
14. Deas-Nesmith D., Campbell S., Brady K.T. Substance use disorders in an adolescent inpatient psychiatric population. Journal of the National Medical Association 1998, 90:233-238.
15. Farmer E.M., Compton S.N., Bums B.J., Robertson E. Review of the evidence base for treatment of childhood psychopathology: externalizing disorders. Journal of Consulting and Clinical Psychology 2002, 70:1267-1302.
16. Garland A.F., Hough R.L., McCabe K.M., Yeh M., Wood P.A., Aarons G.A. Prevalence of psychiatric disorders in youths across five sectors of care. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:409-418.
17. Garland A.F., Lau A.S., Yeh M., McCabe K.M., Hough R.L., Landsverk J.A. Racial and ethnic differences in utilization of mental health services among high-risk youths. American Journal of Psychiatry 2005, 162:1336-1343.
18. Gersing K.R., Krishnan K.R. Practical evidence-based medicine. Psychopharmacology Bulletin 2002, 36:20-26.
19. Gersing K., Krishnan R. Clinical computing: Clinical Management Research Information System (CRIS). Psychiatric Services 2003, 54:1199-1200.
20. Gersing K., Burchett B., March J., Ostbye T., Krishnan K.R. Predicting antipsychotic use in children. Psychopharmacology Bulletin 2007, 40:116-124.
21. Goldstein B.I., Bukstein O.G. Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention. Journal of Clinical Psychiatry 2010, 71:348-358.
22. Halamandaris P.V., Anderson T.R. Children and adolescents in the psychiatric emergency setting. The Psychiatric Clinics of North America 1999, 22:865-874.
23. Hillemeier M.M., Foster E.M., Heinrichs B., Heier B., Conduct Problems Prevention Research Group Racial differences in parental reports of attention-deficit/hyperactivity disorder behaviors. Journal of Developmental and Behavioral Pediatrics 2007, 28:353-361.
24. Institute of Medicine Initial national priorities for comparative effectiveness research 2009, Institute of Medicine, Washington, DC.
25. Jha A.K., DesRoches C.M., Kralovec P.D., Joshi M.S. A progress report on electronic health records in U.S. hospitals. Health Affairs (Millwood) 2010, 29:1951-1957.
26. Johnston L.D., O'Malley P.M., Bachman J., Schulenberg J.E. Monitoring the Future national results on adolescent drug use: overview of key findings, 2010 2011, Institute for Social Research, University of Michigan, Ann Arbor.
27. Kandel D.B., Johnson J.G., Bird H.R., Weissman M.M., Goodman S.H., Lahey B.B., et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. Journal of the American Academy of Child and Adolescent Psychiatry 1999, 38:693-699.
28. Kelly J.F., Myers M.G. Adolescents' participation in Alcoholics Anonymous and Narcotics Anonymous: review, implications and future directions. Journal of Psychoactive Drugs 2007, 39:259-269.
29. Kendall P.C., Kessler R.C. The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations. Journal of Consulting and Clinical Psychology 2002, 70:1303-1306.
30. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:593-602. [Erratum in: Archives of General Psychiatry 2005;62:768].
31. Kilgus M.D., Pumariega A.J., Cuffe S.P. Influence of race on diagnosis in adolescent psychiatric inpatients. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:67-72.
32. Kramer T.L., Robbins J.M., Phillips S.D., Miller T.L., Burns B.J. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. Journal of the American Academy of Child and Adolescent Psychiatry 2003, 42:1318-1326.
33. Large M., Sharma S., Compton M.T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry 2011, 68:555-561.
34. Leung A., Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica Supplementum 2000, 401:3-38.
35. Lewinsohn P.M., Hops H., Roberts R.E., Seeley J.R., Andrews J.A. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology 1993, 102:133-144.
36. Libby A.M., Riggs P.D. Integrated substance use and mental health treatment for adolescents: aligning organizational and financial incentives. Journal of Child and Adolescent Psychopharmacology 2005, 15:826-834.
37. Lubman D.I., Allen N.B., Rogers N., Cementon E., Bonomo Y. The impact of co-occurring mood and anxiety disorders among substance-abusing youth. Journal of Affective Disorders 2007, 103(1-3):105-112.
38. McGilloway A., Hall R.E., Lee T., Bhui K.S. A systematic review of personality disorder, race and ethnicity: prevalence, aetiology and treatment. BMC Psychiatry 2010, 10:33.
39. Merikangas K.R., He J.P., Burstein M., Swanson S.A., Avenevoli S., Cui L., et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49:980-989.
40. Muroff J., Edelsohn G.A., Joe S., Ford B.C. The role of race in diagnostic and disposition decision making in a pediatric psychiatric emergency service. General Hospital Psychiatry 2008, 30:269-276.
41. Najt P., Fusar-Poly P., Brambilla P. Co-occurring mental and substance abuse disorders: a review on the potential predictors and clinical outcomes. Psychiatry Research 2011, 186(2-3):159-164.
42. National Center on Addiction and Substance Abuse Non-medical marijuana III: rite of passage or Russian roulette? 2008, The National Center on Addiction and Substance Abuse at Columbia University, New York, NY.
43. O'Neil K.A., Conner B.T., Kendall P.C. Internalizing disorders and substance use disorders in youth: comorbidity, risk, temporal order, and implications for intervention. Clinical Psychology Review 2011, 31(1):104-112.
44. ProCon.org. Should marijuana be a medical option? Available at: [accessed 13.11.10]. http://medicalmarijuana.procon.org/.
45. Rao U., Daley S.E., Hammen C. Relationship between depression and substance use disorders in adolescent women during the transition to adulthood. Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39:215-222.
46. Riggs P.D. Treating adolescents for substance abuse and comorbid psychiatric disorders. Science & Practice Perspectives 2003, 2:18-29.
47. Roberts R.E., Roberts C.R., Xing Y. Comorbidity of substance use disorders and other psychiatric disorders among adolescents: evidence from an epidemiologic survey. Drug and Alcohol Dependence 2007, 88(Suppl. 1):S4-S13.
48. Rowe C.L., Liddle H.A., Greenbaum P.E., Henderson C.E. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. Journal of Substance Abuse Treatment 2004, 26:129-140.
49. SAS version 9.2 2010, SAS Institute, Cary, NC, USA.
50. Shapiro G.K., Buckley-Hunter L. What every adolescent needs to know: cannabis can cause psychosis. Journal of Psychosomatic Research 2010, 69:533-539.
51. Shrier L.A., Harris S.K., Kurland M., Knight J.R. Substance use problems and associated psychiatric symptoms among adolescents in primary care. Pediatrics 2003, 111(6 Pt 1):e699-e705.
52. Stevens J., Harman J.S., Kelleher K.J. Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. Journal of Child and Adolescent Psychopharmacology 2005, 15:88-96.
53. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Treatment Episode Data Set (TEDS) highlights-2007 national admissions to substance abuse treatment services 2009, OAS Series #S-45, HHS Publication No. (SMA) 09-4360, Substance Abuse and Mental Health Services Administration, Rockville, MD.
54. Waxmonsky J.G., Wilens T.E. Pharmacotherapy of adolescent substance use disorders: a review of the literature. Journal of Child and Adolescent Psychopharmacology 2005, 15:810-825.
55. Weaver M.F., Dupre M.A., Cropsey K.L., Koch J.R., Sood B.A., Wiley J.L., et al. Addiction epidemiology in adolescents receiving inpatient psychiatric treatment. Addictive Behaviors 2007, 32:3107-3113.
56. Wu L.T., Pilowsky D.J., Schlenger W.E. High prevalence of substance use disorders among adolescents who use marijuana and inhalants. Drug and Alcohol Dependence 2005, 78:23-32.
57. Wu L.T., Ringwalt C.L. Use of alcohol treatment and mental health services among adolescents with alcohol use disorders. Psychiatric Services 2006, 57:84-92.
58. Wu LT, Woody GE, Yang C, Pan JJ, Blazer DG. Racial/ethnic variations in alcohol and drug use disorders among adolescents in the United States. Archives of General Psychiatry, in press.
59. Zeitlin H. Psychiatric comorbidity with substance misuse in children and teenagers. Drug and Alcohol Dependence 1999, 55:225-234.